Nohria, A., Desai, D., Shapiro, J., Bordone, L., & Lo Sicco, K. (2024). Review of the use of Janus kinase inhibitors in the treatment of scarring alopecia. International Journal of Dermatology, 63(6). Portico. https://doi.org/10.1111/ijd.17153

Di Matteo, A., Bathon, J. M., & Emery, P. (2023). Rheumatoid arthritis. The Lancet, 402(10416), 2019–2033. https://doi.org/10.1016/s0140-6736(23)01525-8

Son, A., Meylan, F., Gomez-Rodriguez, J., Kaul, Z., Sylvester, M., Falduto, G. H., Vazquez, E., Haque, T., Kitakule, M. M., Wang, C., Manthiram, K., Qi, C.-F., Cheng, J., Gurram, R. K., Zhu, J., Schwartzberg, P., Milner, J. D., Frischmeyer-Guerrerio, P. A., & Schwartz, D. M. (2023). Dynamic chromatin accessibility licenses STAT5- and STAT6-dependent innate-like function of TH9 cells to promote allergic inflammation. Nature Immunology, 24(6), 1036–1048. https://doi.org/10.1038/s41590-023-01501-5

Dai, Z., Sezin, T., Chang, Y., Lee, E. Y., Wang, E. H. C., & Christiano, A. M. (2022). Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.955038

Ruperto, N., Brunner, H. I., Synoverska, O., Ting, T. V., Mendoza, C. A., Spindler, A., Vyzhga, Y., Marzan, K., Grebenkina, L., Tirosh, I., Imundo, L., Jerath, R., Kingsbury, D. J., Sozeri, B., Vora, S. S., Prahalad, S., Zholobova, E., Butbul Aviel, Y., Chasnyk, V., … Weiss, J. (2021). Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. The Lancet, 398(10315), 1984–1996. https://doi.org/10.1016/s0140-6736(21)01255-1

Assal, A., & Mapara, M. Y. (2021). Janus Kinase Inhibitors and Cell Therapy. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.740847